How AI and RWD Are Redefining TV Advertising for Pharma Marketers

By: Emilie Branch, Content Manager, Swoop

Kurt Robinson, Senior Vice President of Business Development for Swoop, spoke with Marc Iskowitz, editor-at-large of MM+M to discuss how custom audiences are transforming TV advertising for the life sciences industry. Pharmaceutical advertising’s traditional reliance on demographic data to inform television media strategy leads to wasteful spend on an overexposed audience and an unoptimized marketing mix. By utilizing brand-exclusive audiences built using AI and real world data that are higher in audience quality, healthcare marketers can optimize their TV advertising reach and frequency for improved engagement and increased script lift.

About the Author

Emilie Branch 

Content Manager

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.